drugset / Trial / NCT00610883
LSA4 Protocol for the Treatment of Advanced Pediatric and Adolescent Non-Hodgkins Lymphoma
NaSingle-groupOpen-labelTreatment
Summary
Non-Hodgin's lymphoma is curable in 76% of patients. In nonlymphoblastic lymphmas, cancer may return on average 3 months from beginning treatment and for lymphoblastic lymphomas, 6 months. To aggressively treat this cancer this study uses effective drugs in three parts: * Induction ends on day 19 * Consolidation ends on day 38 or 42 * Maintenance may include up to 6 cycles
Timeline
- Start
- 1990-05
- Primary completion
- 2008-12
- Completion
- 2008-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cyclophosphamide | Other / unclassified | — | — |
| Subject | Daunorubicin | Small molecule | — | — |
| Subject | Methotrexate | Small molecule | — | — |
| Subject | asparaginase | Protein / enzyme biologic | — | — |
| Subject | carmustine | Small molecule | — | — |